Invention Grant
- Patent Title: Chemosensory receptor ligand-based therapies
- Patent Title (中): 基于化学感受器官配体的疗法
-
Application No.: US13978514Application Date: 2012-01-06
-
Publication No.: US09050292B2Publication Date: 2015-06-09
- Inventor: Alain D. Baron , Martin R. Brown , Christopher R. G. Jones , Nigel R. A. Beeley , Mark S. Fineman
- Applicant: Alain D. Baron , Martin R. Brown , Christopher R. G. Jones , Nigel R. A. Beeley , Mark S. Fineman
- Applicant Address: US CA San Diego
- Assignee: Elcelyx Therapeutics, Inc.
- Current Assignee: Elcelyx Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Arnold & Porter LLP
- Agent Todd A. Lorenz, Esq.
- International Application: PCT/US2012/020548 WO 20120106
- International Announcement: WO2012/094636 WO 20120712
- Main IPC: A61K31/155
- IPC: A61K31/155 ; A61K9/20 ; A61K9/24 ; A61K9/28 ; A61K9/48 ; A61K9/00 ; A61K31/19 ; A61K31/198 ; A61K31/7016 ; A61K31/704 ; A61K45/06
Abstract:
Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a chemosensory receptor ligand, such as a bitter receptor ligand. Also provided herein are chemosensory receptor ligand compositions, including bitter receptor ligand compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
Public/Granted literature
- US20140030332A1 Chemosensory Receptor Ligand-Based Therapies Public/Granted day:2014-01-30
Information query
